Microchip Technology Inc
—- Market cap
- —
- Debt
- —
- Cash
- −$240.30M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MCHP stock price vs CGNX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CGNX's multiple
Needs CGNX P/E.
Implied fair value · at MCHP's multiple
Needs MCHP P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MICROCHIP TECHNOLOGY INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
COGNEX CORP · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
INTEL CORP
MCHP vs INTC
TEXAS INSTRUMENTS INC
MCHP vs TXN
ADVANCED MICRO DEVICES INC
MCHP vs AMD
QUALCOMM INC/DE
MCHP vs QCOM
APPLIED MATERIALS INC /DE
MCHP vs AMAT
SKYWORKS SOLUTIONS, INC.
MCHP vs SWKS
TELEDYNE TECHNOLOGIES INC
MCHP vs TDY
TERADYNE, INC
MCHP vs TER
ZEBRA TECHNOLOGIES CORP
MCHP vs ZBRA
METTLER TOLEDO INTERNATIONAL INC/
MCHP vs MTD
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe MCHP can materially improve margins and reduce leverage toward CGNX-like levels, then hold off on adding aggressively; otherwise, the current valuation looks hard to justify because the implied P/E price is far below the market price and the operating quality gap versus CGNX is unfavorable.
On the provided P/E framework, MCHP’s current price of $75.22 implies a value of $21.54, or -71.4% downside, indicating a large valuation disconnect. The stock also trades above the DCF range and near the top of its historical band, which supports a cautious relative-valuation view.
Supporting Metrics